You are here

Home » CERID Bibliography

CERID Bibliography

Export 86 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is F  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
F
Futse JE, Brayton KA, Dark MJ, Knowles DP, Palmer GH. Superinfection as a driver of genomic diversification in antigenically variant pathogens. Proc Natl Acad Sci U S A. 2008 ;105(6):2123-7.
Futse JE, Brayton KA, Nydam SD, Palmer GH. Generation of antigenic variants via gene conversion: Evidence for recombination fitness selection at the locus level in Anaplasma marginale. Infect Immun. 2009 ;77(8):3181-7.
Futse JE, Ueti MW, Knowles DP, Palmer GH. Transmission of Anaplasma marginale by Boophilus microplus: retention of vector competence in the absence of vector-pathogen interaction. J Clin Microbiol. 2003 ;41(8):3829-34.
Futse JE, Brayton KA, Knowles DP, Palmer GH. Structural basis for segmental gene conversion in generation of Anaplasma marginale outer membrane protein variants. Mol Microbiol. 2005 ;57(1):212-21.
Fritsche G, Nairz M, Libby SJ, Fang FC, Weiss G. Slc11a1 (Nramp1) impairs growth of Salmonella enterica serovar typhimurium in macrophages via stimulation of lipocalin-2 expression. J Leukoc Biol. 2012 ;92(2):353-9.
Frick PA, Black DJ, Duchin JS, Deliganis S, McKee WM, Fritsche TR. Prevalence of antimicrobial drug-resistant Streptococcus pneumoniae in Washington State. West J Med. 1998 ;169(6):364-9.
Frevert CW, Boggy G, Keenan TM, Folch A. Measurement of cell migration in response to an evolving radial chemokine gradient triggered by a microvalve. Lab Chip. 2006 ;6(7):849-56.
Frevert CW, Farone A, Danaee H, Paulauskis JD, Kobzik L. Functional characterization of rat chemokine macrophage inflammatory protein-2. Inflammation. 1995 ;19(1):133-42.
Frevert CW, Matute-Bello G, Martin TR. Rabbit models of pneumonia, peritoneal sepsis, and lung injury. Methods Mol Biol. 2000 ;138:319-30.
Frevert CW, Goodman RB, Kinsella MG, Kajikawa O, Ballman K, Clark-Lewis I, Proudfoot AEI, Wells TNC, Martin TR. Tissue-specific mechanisms control the retention of IL-8 in lungs and skin. J Immunol. 2002 ;168(7):3550-6.
Frevert CW, Warner AE. Respiratory distress resulting from acute lung injury in the veterinary patient. J Vet Intern Med. 1992 ;6(3):154-65.
Frevert CW, Wong VA, Goodman RB, Goodwin R, Martin TR. Rapid fluorescence-based measurement of neutrophil migration in vitro. J Immunol Methods. 1998 ;213(1):41-52.
Frevert CW, Kinsella MG, Vathanaprida C, Goodman RB, Baskin DG, Proudfoot A, Wells TNC, Wight TN, Martin TR. Binding of interleukin-8 to heparan sulfate and chondroitin sulfate in lung tissue. Am J Respir Cell Mol Biol. 2003 ;28(4):464-72.
Frevert CW, Warner AE, Kobzik L. Defective pulmonary recruitment of neutrophils in a rat model of endotoxemia. Am J Respir Cell Mol Biol. 1994 ;11(6):716-23.
Frevert CW, Warner AE, Weller E, Brain JD. The effect of endotoxin on in vivo rat alveolar macrophage phagocytosis. Exp Lung Res. 1998 ;24(6):745-58.
Frevert CW, Martin TR. Sepsis and the lung host response. Semin Respir Crit Care Med. 2004 ;25(1):85-93.
Frevert CW, Huang S, Danaee H, Paulauskis JD, Kobzik L. Functional characterization of the rat chemokine KC and its importance in neutrophil recruitment in a rat model of pulmonary inflammation. J Immunol. 1995 ;154(1):335-44.
Frevert CW, Matute-Bello G, Skerrett SJ, Goodman RB, Kajikawa O, Sittipunt C, Martin TR. Effect of CD14 blockade in rabbits with Escherichia coli pneumonia and sepsis. J Immunol. 2000 ;164(10):5439-45.
French DM, McElwain TF, McGuire TC, Palmer GH. Expression of Anaplasma marginale major surface protein 2 variants during persistent cyclic rickettsemia. Infect Immun. 1998 ;66(3):1200-7.
French DM, Brown WC, Palmer GH. Emergence of Anaplasma marginale antigenic variants during persistent rickettsemia. Infect Immun. 1999 ;67(11):5834-40.
Fredricks D, Ramakrishnan L. The Acetobacteraceae: extending the spectrum of human pathogens. PLoS Pathog. 2006 ;2(4):e36.
Fredericksen BL, Smith M, Katze MG, Shi P-Y, Gale M. The host response to West Nile Virus infection limits viral spread through the activation of the interferon regulatory factor 3 pathway. J Virol. 2004 ;78(14):7737-47.
Fredericksen BL, Gale M. West Nile virus evades activation of interferon regulatory factor 3 through RIG-I-dependent and -independent pathways without antagonizing host defense signaling. J Virol. 2006 ;80(6):2913-23.
Fredericksen B, Akkaraju GR, Foy E, Wang C, Pflugheber J, Chen ZJ, Gale M. Activation of the interferon-beta promoter during hepatitis C virus RNA replication. Viral Immunol. 2002 ;15(1):29-40.
Fredericksen BL, Keller BC, Fornek J, Katze MG, Gale M. Establishment and maintenance of the innate antiviral response to West Nile Virus involves both RIG-I and MDA5 signaling through IPS-1. J Virol. 2008 ;82(2):609-16.

Pages